Jodi M. Hale CPO, LPO

Recommended Articles

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• Are Relatives of Someone with Breast Cancer Automatically at Risk?

  It is only natural to be concerned as to whether there is an increased risk of cancer in your family if you or one of your close family members (mother, father, brother, sister, son, or daughter) have been diagnosed with breast cancer. This is known as a family history of cancer. However, most...

• What if I Do Not Want My Child to Undergo MMR Vaccination?

  The MMR (measles, mumps, and rubella) vaccine is recommended for all children as it is the safest, most effective way to protect children against three diseases that can have serious, even fatal, consequences.  Measles is a highly contagious viral infection whose initial symptoms include fever,...

• Freezing and Cauterization of Genital Warts

  Genital warts may appear in/around the anus, in the pubic area and or in the vagina. They appear like pink or red growth in or around the sex organs. They often appear in clusters of 3-4.They may grow and spread rapidly. They are usually painless but sometimes might cause mild pain, itching and...

• What are the Causes and Symptoms of Glaucoma?

  Glaucoma is a group of conditions that leads to the impairment of the optic nerve that carries information from the eyes to the brain. It is a progressive condition, which, if not treated, may lead to complete loss of vision. The most common cause of this damage is the increase in the pressure...

• Is There Ever Enough Ovarian Cancer Research?

  Recently, there has been much progress made in research of gynecological cancers. Many report that this period has been exceptionally productive in the field. However, despite how positive this is, many with gynecological cancers are upset that clinical trials are becoming decreasingly available, as...